$2.52
$0.00 (0.00%)
End-of-day quote: 05/18/2024
NasdaqCM:NERV
Minerva Neurosciences Annual Report
| Year | Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.00M | $41.18M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M | ||
| GM % | Gross Margin % |
|
0.00% | 0.00% | 46.47% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| OM | Operating Margin |
|
0.00% | 0.00% | 4.49% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| EPS | Earnings Per Share |
|
$0.00 | $-4.61 | $-6.01 | $-9.36 | $0.40 | $-14.80 | $-10.32 | $-8.62 | $-7.92 | $-9.28 | $-35.76 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| PR % | Payout Ratio % |
|
0 | 0 | 0.00% | -0.00% | -0.00% | -0.00% | 0 | 0 | 0 | ||
| Sha. | Shares |
|
5.34m | 5.34m | 5.34m | 4.89m | 4.87m | 4.84m | 4.38m | 3.09m | 2.3m | ||
| OCF | Operating Cash Flow |
|
$-24.65M | $-24.60M | $-33.82M | $-43.43M | $-41.94M | $3.09M | $-25.69M | $-24.27M | $-35.96M | ||
| FCF | Free Cash Flow |
|
$-24.67M | $0.00M | $-33.82M | $-43.43M | $-41.94M | $3.04M | $-25.69M | $0.00M | $-36.01M | ||
| FCFS | Free Cash Flow Per Share |
|
$-4.62 | $-4.61 | $-6.63 | $-8.91 | $-8.65 | $0.64 | $-6.52 | $-8.29 | $-22.64 |
